214 related articles for article (PubMed ID: 26875774)
21. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.
Tong Z; Liu N; Lin L; Guo X; Yang D; Zhang Q
Biomed Pharmacother; 2015 Oct; 75():129-36. PubMed ID: 26297542
[TBL] [Abstract][Full Text] [Related]
22. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
23. Integrated proteomics and metabolomics analysis reveals hubs protein and network alterations in myasthenia gravis.
Tong T; Zhang J; Jia L; Liang P; Wang N
Aging (Albany NY); 2022 Jul; 14(13):5417-5426. PubMed ID: 35802752
[TBL] [Abstract][Full Text] [Related]
24. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.
Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ
Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484
[TBL] [Abstract][Full Text] [Related]
25. miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis.
Xin Y; Cai H; Lu T; Zhang Y; Yang Y; Cui Y
Biomed Res Int; 2016; 2016():9595718. PubMed ID: 27833920
[No Abstract] [Full Text] [Related]
26. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
[TBL] [Abstract][Full Text] [Related]
27. Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs.
Fiorillo AA; Heier CR; Huang YF; Tully CB; Punga T; Punga AR
Front Immunol; 2020; 11():151. PubMed ID: 32153563
[TBL] [Abstract][Full Text] [Related]
28. miR-125a-5p expression is associated with the age of breast cancer patients.
He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
[TBL] [Abstract][Full Text] [Related]
29. MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ.
Yuan J; Xiao G; Peng G; Liu D; Wang Z; Liao Y; Liu Q; Wu M; Yuan X
Biochem Biophys Res Commun; 2015 Feb; 457(2):171-6. PubMed ID: 25542152
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune regulator expression in thymomas with or without autoimmune disease.
Liu Y; Zhang H; Zhang P; Meng F; Chen Y; Wang Y; Yao Y; Qi B
Immunol Lett; 2014 Sep; 161(1):50-6. PubMed ID: 24768600
[TBL] [Abstract][Full Text] [Related]
31. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
Huang P; Mao LF; Zhang ZP; Lv WW; Feng XP; Liao HJ; Dong C; Kaluba B; Tang XF; Chang S
Thyroid; 2018 May; 28(5):613-623. PubMed ID: 29634399
[TBL] [Abstract][Full Text] [Related]
32. Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients.
Punga AR; Andersson M; Alimohammadi M; Punga T
J Neurol Sci; 2015 Sep; 356(1-2):90-6. PubMed ID: 26095457
[TBL] [Abstract][Full Text] [Related]
33. miR-125a-5p: a novel regulator of SLC26A6 expression in intestinal epithelial cells.
Anbazhagan AN; Priyamvada S; Borthakur A; Saksena S; Gill RK; Alrefai WA; Dudeja PK
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C200-C208. PubMed ID: 31042422
[TBL] [Abstract][Full Text] [Related]
34. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
[TBL] [Abstract][Full Text] [Related]
35. Effects of miR-125a-5p on Cell Proliferation,Apoptosis and Cell Cycle of Pancreatic Cancer Cells.
Jia CW; Sun Y; Zhang TT; Lu ZH; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Aug; 38(4):415-21. PubMed ID: 27594154
[TBL] [Abstract][Full Text] [Related]
36. Thymoma related myasthenia gravis in humans and potential animal models.
Marx A; Porubsky S; Belharazem D; Saruhan-Direskeneli G; Schalke B; Ströbel P; Weis CA
Exp Neurol; 2015 Aug; 270():55-65. PubMed ID: 25700911
[TBL] [Abstract][Full Text] [Related]
37. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
38. Forkhead box p3 controls progression of oral lichen planus by regulating microRNA-146a.
Wang J; Yang L; Wang L; Yang Y; Wang Y
J Cell Biochem; 2018 Nov; 119(11):8862-8871. PubMed ID: 30125971
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD.
Kim H; Choi H; Lee SK
Cancer Lett; 2015 Jan; 356(2 Pt B):733-42. PubMed ID: 25449437
[TBL] [Abstract][Full Text] [Related]
40. cFLIP overexpression in T cells in thymoma-associated myasthenia gravis.
Belharazem D; Schalke B; Gold R; Nix W; Vitacolonna M; Hohenberger P; Roessner E; Schulze TJ; Saruhan-Direskeneli G; Yilmaz V; Ott G; Ströbel P; Marx A
Ann Clin Transl Neurol; 2015 Sep; 2(9):894-905. PubMed ID: 26401511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
